J&J’s Profit Falls on Strong Dollar

A stronger U.S. dollar and weak medical-device sales pressured Johnson & Johnson’s first-quarter results and full-year outlook, while the health-care giant leaned on its growing pharmaceutical unit to partially offset declines in other segments.

Speak Your Mind

Subscribe to get this amazing EBOOK FREE

Real Estate 101 - Buying Your First Home!

By subscribing to this newsletter you agree to our Privacy Policy